Search for: "Pharmaceutical Research and Manufacturers of America" Results 21 - 40 of 410
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2022, 7:01 am by Kyle Hulehan
For one, it is possible that a carbon tax enacted only in America could merely move polluting activity abroad rather than drive down the overall level of carbon emissions. [read post]
14 Oct 2022, 5:16 am by Chenny Zhang
Over the years, CMOs have moved up the value chain by offering CRO-like research services to essentially become a “one-stop-shop” for drugmakers looking to outsource noncore capabilities like research and manufacturing. [read post]
12 Oct 2022, 9:05 pm by Trevor Kirby
In opposition to President Trump’s attempted reform, the Pharmaceutical Research and Manufacturers of America (PhRMA)—a voluntary association of pharmaceutical and biotechnology companies—has argued that permitting the Secretary of HHS to negotiate down drug prices would impede drug manufacturers’ ability to innovate new drugs. [read post]
2 Oct 2022, 4:55 pm by Kurt R. Karst
After the OIG Special Fraud Alert, the Pharmaceutical Research and Manufacturers of America (PhRMA) updated its Code on Interactions with Health Care Professionals to offer updated guidance on speaker trainings, speaker programs, meals, and gifts. [read post]
7 Sep 2022, 2:20 am by Kurt R. Karst
  The largest number of import alerts were from sites in China and Latin America, the latter owing to the large number of facilities that manufactured hand sanitizer that were detained at the border. [read post]
  Industry groups representing pharmaceutical and device manufacturers (Pharmaceutical Research and Manufacturers of America (PhRMA) and Advanced Medical Technology Association (AdvaMed)) have recently updated their voluntary codes of conduct regarding interactions with healthcare providers to incorporate and provide guidance on many of the points raised by the OIG Special Fraud Alert. [read post]
26 Jul 2022, 10:13 am by Irene
Other Ricchetti Inc. earnings recorded in the latest quarterly disclosure include Amazon ($90,000), Pharmaceutical Research and Manufactures of America ($60,000) and General Motors ($60,000). [read post]
New research from the Center for Public Health Law Research funded by the Pharmaceutical Research and Manufacturers of America (PhRMA), used policy surveillance to examine financial assistance and related debt collection policies from 75 of the largest 340B hospitals in the country (51 largest 340B hospitals by revenue in each state and the District of Columbia along with the 24 next largest 340B hospitals by revenue for the 2017-2018 or… [read post]
14 Jul 2022, 7:01 am by Raquel Leslie, Brian Liu
According to market research company Insider Intelligence, TikTok commanded a 20 percent market share in 2022, which is expected to rise to 25 percent by 2024. [read post]
3 Jul 2022, 7:15 am by Jae Um
The longest-standing democracy in the world looks and feels bitterly divided. [read post]
“National critical capabilities” are defined as those identified necessary for supply chains identified pursuant to the supply chain review mandated by Executive Order 14017, including: semiconductor manufacturing materials, large capacity batteries, critical minerals and materials, pharmaceuticals and active pharmaceutical ingredients, and “critical and emerging technologies,” such as artificial intelligence, bioeconomy, and quantum information… [read post]
” Pharma companies also oppose the deal, with Stephen Ubl, president of the Pharmaceutical Research and Manufacturers of America, saying, “Rather than focus on real issues affecting public health, like solving supply chain bottlenecks or reducing border tariffs on medicines, they approved an intellectual property waiver on COVID-19 vaccines that won’t help protect people against the virus. [read post]
3 Jun 2022, 10:03 am by Robert B. Milligan
In the case, a pharmaceutical company sued a former product development employee and his new employer in the District of New Jersey for misappropriation of trade secrets in violation of the DTSA. [read post]
24 May 2022, 11:35 am by USPTO
” The paper summarizes the responses we received about whether the USPTO’s interpretation of the “article of manufacture” requirement for design patents should be reevaluated to incentivize and protect design innovation in new and emerging technologies, including projections, holographic imagery, and virtual and augmented reality. [read post]
19 May 2022, 2:10 am by Kurt R. Karst
By Faraz Siddiqui —Last June, we blogged about a lawsuit brought by the Pharmaceutical Research and Manufacturers of America (PhRMA) challenging CMS’s ill-conceived Accumulator Adjustment Rule (“final rule”), which amended the Medicaid Rebate best price regulation. [read post]
4 May 2022, 8:14 am by Dan Bressler
” “‘The Center for Drugs currently does not have a contract with McKinsey and across FDA,’ said Patrizia Cavazzoni, director of the Center for Drug Evaluation and Research for the FDA. [read post]
3 May 2022, 1:55 am by Kevin Kaufman
As of 2019, China held nearly $1.3 trillion in U.S. government debt, and another $203 billion in U.S. private sector bonds and equities.[3] Due to Chinese restrictions on portfolio investment, U.S. investment in China has mostly taken the form of foreign direct investment (FDI), primarily in manufacturing. [read post]
22 Mar 2022, 6:00 am by Sarah Cummings and Katie Pawlitz
AdvaMed’s newest guidance follows shortly behind an August 2021 announcement by the Pharmaceutical Research and Manufacturers of America (PhRMA) – which represents the nation’s leading biopharmaceutical research companies – that it updated its Code on Interactions with Health Care Professionals, to address many of the same topics. [read post]
18 Feb 2022, 7:33 am by Jonathan M. Barnett
A handful of U.S. and European firms lead in wireless chip design and rely on patent licensing to disseminate technology to device manufacturers and to fund billions of dollars in research and development. [read post]